Obagi Medical Products, Inc. (OMPI) Tops Q4 EPS by 5c

Obagi Medical Products, Inc. (NASDAQ: OMPI) reported Q4 EPS of $0.24, $0.05 better than the analyst estimate of $0.19. Revenue for the quarter came in at $30.6 million versus the consensus estimate of $30.64 million.

For earnings history and earnings-related data on Obagi Medical Products, Inc. (OMPI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BMO starts chip stocks coverage: Here are its preferred picks
• S&P 500 may pull back before midterms, but Citi says buy the dip